pediatric

In the Zone: A day in the life of a pediatric cardiac surgeon

by Columbia Surgery on February 10, 2012

Emile Bacha, MD

Emile Bacha, MD

Interview with Emile Bacha, MD, Chief, Division of Cardiothoracic Surgery at NewYork-Presbyterian Hospital/Columbia University Medical Center

In this interview, Dr. Bacha, Chief of the Division of Cardiothoracic Surgery at NewYork-Presbyterian/Columbia, provides a glimpse into what it is like to perform open heart surgery on children every day, and what it takes to excel in such demanding circumstances. Having previously served as the director of pediatric heart surgery programs at Children’s Hospital in Boston and the University Hospitals of Chicago, Dr. Bacha has had many years of experience in learning how to be at one’s absolute best, day in and day out, when a child’s life is on the line.

Q: You describe something you consider indispensable to being a successful surgeon: the ability to be “in the zone,” as you put it. How would you describe being “in the zone?”

Dr. Bacha: Being “in the zone” means maintaining complete focus, concentration, and equanimity so that nothing distracts you from the task at hand. And this has to be done under any circumstance. It means being able to control your emotions so you can focus exclusively on the patient’s heart surgery. It means leaving your problems, whatever they may be — spousal, financial or whatever — at the door in the OR. It means not losing composure no matter what else may be going on.

Q: Why is this important?

Dr. Bacha: Being able to be “in the zone” really differentiates a successful surgeon from one who isn’t as successful. If you have a patient dying before your eyes, a limited time to do an operation, and the clock is ticking, are you able to hold it together and do the right thing? Or do you compensate by falling apart, or yelling or lashing out at your colleagues? In the field of pediatric cardiac surgery, emotions are especially magnified because we are dealing with a child’s life. Going through years of training is not enough; I have seen doctors who have had impeccable training and who are extremely ‘book-smart’ but who break down under pressure in the operating room. If you’re not able to control your emotions, you can’t function at a high level day after day after day.

I teach my residents that the tougher and the more acute it gets in the OR, the slower you should get. Because the adrenaline is flowing, you are usually not slower, but in fact achieve a sort of middle range where you are not hasty in your decisions and actions. Remember that a surgeon has to be physically proficient as well as intellectually. That is, you can be the smartest surgeon in the world, but if that stitch is not placed perfectly, the patient will die no matter how smart you are. Another thing I teach my residents is that the best teams handle emergencies in an orderly fashion, such that if an observer was watching the team work from the outside, he wouldn’t be able to tell that an emergency was going on.

Q: Was there ever a time you could not stay in the zone?

Dr. Bacha: A few years back, my wife and children got stuck in Lebanon in a war situation. They were at my mother’s house, and bombs were falling, and I was terribly worried. That was the one time I could not uncouple myself from what was going on, and I could not go into the operating room, and therefore canceled my cases.

Q: How do you maintain your equanimity – do you have any particular practices that help you stay balanced?

Dr. Bacha: I don’t meditate or do yoga or other practices in particular, no. I do have a stable family life, and I think that’s a big part of it. I think I am lucky because I have found it not too difficult to remain balanced. Other things are harder for me, but I grew up during the Lebanese civil war, with a lot of mayhem around me, so maybe I learned to have some innate order.

Related Link:
NewYork-Presbyterian/Columbia appoints Emile Bacha, MD, Chief of Cardiothoracic Surgery

{ 0 comments }

Approximately 30,000 children are born each year with congenital heart defects (about one percent of all live births) in the United States, and .2 to .3 of these children will require cardiac surgery. The Congenital Heart Center at NewYork-Presbyterian Morgan Stanley Children’s Hospital (NYP-MSCHONY) brings together an integrated team of specialists to provide seamless collaboration and a continuum of care for these young patients.

Treatment options are tailored to the diagnosis and presentation of symptoms for each patient and any other medical conditions that may need to be taken into consideration. Increasingly, many congenital heart defects can now be effectively treated with minimally invasive catheter-based interventions that reduce both risk and recovery duration. These treatments often require only a single day of hospitalization, and can eliminate the need for open-heart surgery. The Congenital Heart Center has particular expertise in pediatric interventional cardiology, a specialty that involves non-surgical treatment of congenital and acquired cardiovascular disorders.

Additionally, the Congenital Heart Center is also one of only a few in the U.S. to have a hybrid program for infants and children who do require surgery but could benefit from a minimally invasive surgical procedure in combination with catheter-based interventions. Hybrid heart surgery refers to techniques that combine conventional surgical procedures with minimally invasive, catheter-based interventions. These alternatives typically involve only a small incision through the breast bone or right chest, and advantages include less pain, elimination of the heart-lung machine (and its associated risks), a faster return to normal activities, as well as cosmetic advantages.

Congenital Heart Center

Congenital Heart Center

In Surgery, Less is More

According to Emile Bacha, MD, Chief of Congenital and Pediatric Cardiac Surgery, patients at the Congenital Heart Center are always evaluated for less invasive treatment options first. In some cases, a hybrid approach will allow the surgeon to treat a condition with a single operation rather than a series of surgeries, or to treat conditions that would otherwise be inoperable. Dr. Bacha explains, “As with any treatment options, hybrid techniques may not be appropriate for every child. Some babies still benefit from more traditional surgical procedures, and surgeons evaluate each patient to determine which procedure carries the best possible benefits and outcomes.”

Hybrid techniques can offer significant benefits for some patients, including infants with difficult-to-treat conditions. Surgeons at the Congenital Heart Center have been successfully using a less invasive hybrid technique for a very difficult-to-treat defect in newborns known as hypoplastic left heart syndrome (HLHS). To survive, babies born with this anomaly must undergo surgery during the first week of life, and until recently the only treatment available was the Norwood procedure, requiring three difficult standard open operations and carrying a 10-20 percent greater risk of mortality (based upon national statistics). Because infants with HLHS require treatment at a very young age, hybrid procedures can be used to provide immediate interventions and delay more invasive surgeries until infants are older and stronger.

Surgical outcomes are currently comparable between the hybrid approach and the Norwood procedure, but the hybrid approach is thought to be safer for high-risk patients such as in infants with a low birth weight or who are born prematurely, in large part by avoiding the use of a heart-lung bypass machine.

The Congenital Heart Center has been widely recognized for excellence in treating congenital cardiac conditions in infants and children. Minimally invasive and hybrid procedures are just another set of state-of-the-art techniques the Congenital Heart Center is able to employ to minimize risks and maximize positive patient outcomes. Incorporating significant experience, expertise, and tailored treatment plans, the Congenital Heart Center is able to provide exemplary treatment and care for young patients across the spectrum of congenital cardiac conditions.

For more information about pediatric heart surgery, please visit childrensnyp.org, download the NewYork-Presbyterian Congenital Heart Center brochure or call 212.305.2688.

{ 0 comments }

Young, Obese, and In Surgery

by Columbia Surgery on January 13, 2012

“It’s like having a precancerous condition that you can treat rather than waiting till it’s cancer,” says Jeffrey L. Zitsman, Director of the Center for Adolescent Bariatric Surgery at NewYork-Presbyterian/Morgan Stanley Children’s Hospital, in a New York Times article January 8, 2012. Yet despite the prospect of a lifetime of obesity, ostracism, and diseases such as diabetes for such patients, nearly half of pediatricians and family doctors say they would never refer a teenager for obesity surgery.

Full Article: Young, Obese and in Surgery

Prevalence of Obesity Among US Adolescents

Prevalence of Obesity Among US Adolescents, aged 12 - 19, 2007-2008


*Obesity defined as BMI ≥ 95th percentile. Total includes racial and ethnic groups not shown separately. Source: National Health and Nutrition Examination Survey, 2007 – 2008.

{ 0 comments }

MSCHONY Outcomes Surpass All in NY State

by Columbia Surgery on January 11, 2012

Morgan Stanley Children's Hospital of New York

The Department of Surgery is pleased to announce that Morgan Stanley Children’s Hospital of New York (MSCHONY) has been recognized by the New York State Department of Health (NYS-DOH) in its most recent report on pediatric congenital cardiac surgery for having the lowest risk-adjusted mortality rate (RAMR) in the state. MSCHONY’s pediatric cardiac surgery program was the only hospital in the New York State to have a RAMR significantly below the state average, and the only center to receive recognition for its exceptional outcomes for the past twelve years.

Congenital heart defects encompass a wide range of abnormalities present at birth. According to the National Heart Lung and Blood Institute, these are the most prevalent forms of birth defects, affecting approximately 35,000 newborns annually, or 8 in 1,000 infants. Approximately .2 to .3 percent of cases require corrective surgery.

The “Pediatric Congenital Cardiac Surgery in New York State, 2006-2009” report uses statistical methodologies to standardize data on all pediatric congenital cardiac surgeries statewide, and then compares the mortality rates of each hospital to the statewide risk-adjusted average. This enables outcomes at all ten hospitals in the state approved to perform pediatric cardiac surgery to be compared, while accounting for differences in outcomes based upon various risk factors and other demographic determinants that may influence patient outcomes. In particular, this adjusts for differences in outcomes for hospitals that perform a higher volume of high-risk procedures.

The statewide mortality rate from 2006-2009 was 3.35 percent for all pediatric congenital cardiac surgery patients. At MSCHONY, the risk-adjusted mortality rate was the lowest in the state, at 1.95 percent. The report also indicates that MSCHONY performed 1,624 pediatric congenital cardiac surgeries between 2006 and 2009, or more than twice the number of procedures performed by the second highest volume surgical center.

In this three year period, 31.5 percent of all pediatric congenital cardiac surgeries in New York State were performed at MSCHONY. While experience alone is not a determinant of successful outcomes, MSCHONY has consistently demonstrated superior outcomes along while demonstrating expertise and extensive experience with a wide range of procedures, including high-risk surgeries.

For more information about pediatric congenital cardiac surgery, please visit New York-Presbyterian Morgan Stanley Children’s Hospital of New York (MSCHONY).

{ 0 comments }

Ventricular Assist Devices (VADs) are small pumps that take over the work of the heart in pumping the blood through the body. Patients who need a heart transplant, but for whom there is no donor heart available, might be given a VAD for what’s called a bridge-to-transplant while they wait for a donor.

PediMag, the pediatric version of the adult device, CentriMag, is an external device designed for short-term use in infants with heart failure. PediMag can also be used to support children after heart transplant surgery if they experience organ rejection and need time for their hearts to rest and heal, according to Jonathan M. Chen, MD, Surgical Director of Pediatric Heart Transplantation at Morgan Stanley Children’s Hospital of New York. Dr. Chen has extensive experience treating children with heart failure and has recently authored an account of his first successful use of the PediMag as a biventricular bridge-to-transplant in an infant.

Thoratec PediMag

The PediMag ventricular assist device is slightly smaller than a BlackBerry phone.

Dr. Chen says that although PediMag has been available in Europe for a number of years, it is only now gaining wider use in the U.S. — although in his view this device is clearly safer than other VADS available in the U.S. “Certain other VADs have the advantage that children can go home while using the device. Yet those pumps pose a serious risk of blood clots and stroke,” Dr. Chen explains. Although risk of stroke can be as high as 35% with other devices, “PediMag has a much lower rate of complications related to clot.” Unlike the older mechanical pumps, PediMag and CentriMag use a magnetically levitated, bearingless technology.

In addition to supporting the heart, PediMag can easily be modified so as to provide extracorporeal membrane oxygenation, or ECMO, in cases where a child’s lungs also need support. This flexibility is highly valuable to surgeons like Dr. Chen, whose patients may have both heart and lung failure. Moreover, not only can PediMag be connected to an ECMO circuit, but it can be done very simply and quickly.

This ease of use is a major advance that benefits young patients, according to Dr. Chen. Historically, devices that did the job of PediMag and CentriMag were hulking machines with a vast array of controls, and they were complicated enough that their use was frequently curtailed by lack of expertise. PediMag is far more streamlined, so that once a patient is hooked up, “Practically any doctor or nurse should be capable of handling it,” says Dr. Chen.

Related Link:
Cardiac Device Update: Wireless LVAD in the Pipeline

{ 2 comments }

Marketwatch Reports on Morgan Stanley Children’s Hospital

by Columbia Surgery on August 2, 2011

Marketwatch.com issued a press release Morgan Stanley Children’s Hospital Highlighted for Leadership in Pediatrics, regarding Morgan Stanley Children’s Hospital leadership in pediatrics. The article referred readers to a new web program available on ORLive.com, where clinicians and families may find an in-depth look at the broad range of programs offered by the Division of Pediatric Surgery at NewYork-Presbyterian Morgan Stanley Children’s Hospital/Columbia University Medical Center. The web program’s content focuses on how the team at Morgan Stanley Children’s Hospital is committed to offering children and their families the highest level of care.

Related Link:
ORLive: Pediatric Surgery at NewYork-Presbyterian Morgan Stanley Children’s Hospital Videos

{ 0 comments }